Home > Healthcare & Medical Devices > Urinary Tract Infection Testing Market

Urinary Tract Infection Testing Market - By Test Type (Urinalysis, Urine Cultures, Susceptibility Testing), By Test Kit Type (Laboratory Test Kits, Home Test Kits), By Application (Urethritis, Cystitis, Pyelonephritis), By End-use & Forecast, 2023 - 2032

  • Report ID: GMI5628
  • Published Date: May 2023
  • Report Format: PDF

Industry Analysis

Urinary Tract Infection Testing Market size was valued at over USD 590 million in 2022 and is slated to exhibit more than 5.7% CAGR from 2023 to 2032 driven by increasing prevalence of urinary tract infections globally.
 

Urinary Tract Infection Testing Market

To get more details on this report: Request Free Sample PDF
 

Urinary tract infection (UTI) testing is a diagnostic process used to detect the presence of bacteria or other pathogens in a patient's urine that may be causing an infection in the urinary tract. UTIs are a common infection, particularly among women, and can cause discomfort, pain, and other health complications if left untreated. Additionally, the high number of type 1 diabetes patients mainly children and adolescents will further propel the market growth since diabetic patients are highly prone to contract UTI.
 

COVID-19 Impact

The recent outbreak of COVID-19 had a moderately negative impact on the urinary tract infection testing industry. While the demand for UTI testing remains relatively stable, the pandemic caused disruptions in the supply chain and reduced access to testing facilities. Furthermore, the pandemic disrupted the supply chain for UTI testing products, including laboratory equipment and reagents. The closure of borders, restrictions on international travel, and supply chain disruptions made it challenging for companies to obtain the necessary raw materials and supplies to manufacture UTI testing products.
 

Also, the pandemic led to a reduction in the number of visits to healthcare facilities for non-COVID-19 related issues, including UTI testing. Patients were hesitant to visit healthcare facilities due to the risk of exposure to the virus, leading to a decrease in the number of UTI tests performed.
 

Urinary Tract Infection Testing Market Trends

Prominent industry players are continuously focusing on product innovation with integration of advanced technologies. Such developments are aimed towards offering simplified and convenient diagnostic test types. Innovations in test kit types will have a positive impact on urinary tract infection testing business expansion. For instance, in August 2022, TestCard announced the launch of a non-invasive home testing kit in UK for the detection of UTI. In addition, it is a smartphone enabled UTI test that allows users to detect UTI through immediate testing results.
 

Urinary Tract Infection Testing Test Type Segmentation

Urinary Tract Infection Testing Market, By Test Type,

To get more details on this report: Request Free Sample PDF
 

The urinary tract infection testing market is segmented by test type into urinalysis, urine cultures, and susceptibility testing. The urinalysis segment held the largest revenue size over USD 270 million in 2022 and is estimated to reach more than USD 470 million by 2032. The increasing ageing population base is anticipated to cause a growth in the demand for urinalysis during the forecast period. Urinary tract infections are more common in the elderly population.
 

A urine analysis examines the urine sample's chemical, visual, and microscopic components. Healthcare professionals are increasingly using urinalysis to identify urinary tract infections (UTIs), as well as liver, kidney, and diabetic issues. This examination can be carried out to assess UTI symptoms during a standard check-up. Furthermore, an increase in the availability of test types coupled with several other businesses working towards creating innovative technology will support the segment's revenue share.
 

Urinary Tract Infection Testing Test Kit Type Segmentation

Global Urinary Tract Infection Testing Market Share, By Test Kit Type

To get more details on this report: Request Free Sample PDF
 

UTI testing market is bifurcated based on the test kit type including laboratory test kits and home test kits. The home test kits segment is anticipated to witness highest CAGR at 5.9% during the forecast period owing to better accuracy. UTI home test kits are designed to detect the presence of urinary tract infections (UTIs) in the comfort of own home. These tests typically use a dipstick or strip that is immersed in a urine sample, and the results are available within minutes. Such benefits offered by the home test kits will drive the segment expansion.
 

Urinary Tract Infection Testing Application Segmentation

Urinary tract infection testing market is bifurcated based on the application including urethritis, cystitis, and pyelonephritis. The cystitis segment is anticipated to grow over USD 560 million by 2032. Cystitis is a type of urinary tract infection that affects the bladder. It is a common condition, especially among women. However, if the severity worsens, antibiotics might be required. Within three days of taking antibiotics, patients with uncomplicated cystitis typically show signs of improvement in their symptoms. Some people have frequent cystitis, which may necessitate long-term or continuing medical care. Thus, the aforementioned factors will foster the industry landscape.
 

Urinary Tract Infection Testing End-use Segmentation

UTI testing market is segmented by end-use into hospitals, diagnostic laboratories, homecare settings, and others. Hospitals segment dominated the global urinary tract infection testing market accounting for more than 44% business share in 2022 and is estimated to witness significant revenue over USD 450 million by 2032. This is attributable to growing number of people suffering from UTIs across developing countries, rising awareness about urinary tract infection testing, and increasing prevalence of diabetes. Further, increasing disposable spending in developed nations will contribute considerably towards adoption of urinary tract infection testing in homecare settings thereby leading to segment progress.
 

Urinary Tract Infection Testing Regional Analysis

U.S. Urinary Tract Infection Testing Market Size

North America urinary tract infection testing market accounted for more than USD 230 million in 2022 and will grow momentously more than USD 400 million by 2032. The affordability of urinary tract infection testing among the target population base and ongoing technological developments for early detection of UTI are primarily responsible for the regional market growth. Further, the region's high healthcare spending on health care management and rising disposable income will propel the expansion of the North America market. Also, the substantial presence of well-established market participants and the favourable regulatory environment result in a number of product approvals and launches, particularly in the U.S.
 

Urinary Tract Infection Testing Industry Leaders

Some of the notable key industry players operating in the UTI testing market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Danaher Corporation, ACON Laboratories Inc., Cardinal Health Inc., Stryker Corporation, SYSMEX CORPORATION, Abbott Laboratories, F. Hoffmann-La Roche Ltd, LabCorp (Laboratory Corporation of America Holdings), Siemens Healthineers Inc., among others. These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new type development and launches to strengthen type offerings as well as gain a competitive edge over others.
 

Urinary Tract Infection Testing Industry News:

  • In July 2020, a UTI detection and management kit was released by the urinary health biotechnology company Uqora, Inc. (Pharmavite, LLC). It features the Clarify quick diagnostic tool, which works in homecare and PoC environments. This product launch has resulted in business expansion of the company globally.
     
  • In September 2021, the company launched its at-home UTI testing kit in the UK. The kit, called "Dip UTI," allows people to test for UTIs from the comfort of their own homes using their smartphones. If the test result indicates the presence of a UTI, the user can then share the result with a healthcare professional for further evaluation and treatment.
     

Urinary tract infection testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report


Market, By Test Type (USD Million)

  • Urinalysis 
  • Urine cultures
  • Susceptibility testing

Market, By Test Kit Type (USD Million)

  • Laboratory test kits
  • Home test kits

Market, By Application (USD Million)

  • Urethritis
  • Cystitis
  • Pyelonephritis

Market, By End-use (USD Million)

  • Hospitals
  • Diagnostic laboratories
  • Homecare settings
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Poland
    • Switzerland
    • Norway
    • Finland
    • Sweden
    • Denmark
    • The Netherlands
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Taiwan
    • Indonesia
    • Vietnam
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Israel

 

Authors: Rupali Swain, Subodh Kharad

Frequently Asked Questions (FAQ) :

Global market for urinary tract infection testing was over USD 590 million in 2022 and will reach over USD 1 billion by 2032.

Hospitals segment will record over USD 450 million by 2032 due to rising cases of UTIs and awareness about UTI testing.

North America UTI testing market size will be more than USD 400 million by 2032 on account of ongoing technological developments for the early detection of UTI.

Thermo Fisher Scientific, Inc., Danaher Corporation, Stryker Corporation, ACON Laboratories Inc., Bio-Rad Laboratories, Cardinal Health Inc., and Abbott Laboratories are the leading providers of urinary tract infection testing.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 357
  • Countries covered: 32
  • Pages: 200
Inquiry Before Buying

Budget constraints? Get in touch with us for special pricing

Request Discount